BioMarin Soars to #4 on Forbes Best Midsize Employers List
Novato-based biotechnology company BioMarin Pharmaceutical Inc. has been ranked fourth on Forbes Magazine’s 2019 list of America’s Best Midsize Employers, a significant leap from ranking 51st on last year’s 2018 list. BioMarin was also ranked first among its peers in the ‘Drugs & Biotechnology’ industry.
“We are honored to again be named one of Forbes Best Employers. It’s a point of pride for all of us at BioMarin that we only develop medicines that are the first or the best of their kind. The medical and scientific firsts in rare diseases that BioMarin has achieved over the last two decades would not be possible without the commitment and passion of the more than 2,900 people who work here,” said Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin. “Our deep connection to patients with rare diseases gives meaning to our work and motivates us to tackle tough scientific problems.”
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. Forbes has previously recognized BioMarin on its “Most Innovative Companies” and “World’s Best Employers” list.